These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7074401)

  • 1. The in-vitro caffeine contracture test: influence of the muscle histochemical profile on test results.
    Brownell AK; Szabo M
    Can Anaesth Soc J; 1982 May; 29(3):218-21. PubMed ID: 7074401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro determination of susceptibility to malignant hyperthermia.
    Iaizzo PA; Lehmann-Horn F
    Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is resting membrane potential a possible indicator of viability of muscle bundles used in the in vitro caffeine contracture test?
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford HG; Dupuis BA
    Anesth Analg; 1992 Jan; 74(1):105-11. PubMed ID: 1734769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fiber types, fascicle size and halothane on caffeine contractures in rat muscles.
    Shah AJ; Pagala MK; Subramani V; Venkatachari SA; Sahgal V
    J Neurol Sci; 1988 Dec; 88(1-3):247-60. PubMed ID: 3225624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
    Britt BA; Frodis W; Scott E; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1982 Nov; 29(6):550-62. PubMed ID: 7139394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
    Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
    Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for malignant hyperpyrexia.
    Nelson TE; Austin KL; Denborough MA
    Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers.
    Williams JH; Holland M; Lee JC; Ward CW; McGrath CJ
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R782-6. PubMed ID: 1718170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine- or halothane-induced contractures of masseter muscle are similar to those of vastus muscle in normal humans.
    Melton AT; Antognini JF; Gronert GA
    Acta Anaesthesiol Scand; 1999 Aug; 43(7):764-9. PubMed ID: 10456818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro diagnosis of susceptibility to malignant hyperthermia: comparison between dynamic and static halothane and caffeine tests.
    Ording H; Skovgaard LT
    Acta Anaesthesiol Scand; 1987 Jul; 31(5):458-61. PubMed ID: 3630590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.
    Isaacs H; Badenhorst M
    Anesthesiology; 1993 Jul; 79(1):5-9. PubMed ID: 8342829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
    Urwyler A; Censier K; Kaufmann MA; Drewe J
    Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia in humans--standardization of contracture testing protocol.
    Melton AT; Martucci RW; Kien ND; Gronert GA
    Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro caffeine test on skeletal muscle samples from swine].
    Rösel U; Szentkuti L
    Dtsch Tierarztl Wochenschr; 1993 Jan; 100(1):25-8. PubMed ID: 8428567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
    Bendixen D; Ording H
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.